Yunlong Li

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Xu Che · 5 shared papers, 2024–2026 · strength 1.48
   • Paper Association between female reproductive factors and new-onset pancreatic cancer risk: a prospective cohort study. DOI 10.1097/cej.0000000000000987↗
   • Paper Elevated circulating glycine levels are associated with reduced pancreatic cancer risk: A prospective cohort study base… DOI 10.1016/j.pan.2025.12.015↗
   • Paper Metabolic signatures of lipid dysregulation and inflammation characterize pancreatic cancer risk in type 2 diabetes mel… DOI 10.1016/j.diabres.2026.113230↗
2. Shuai Xiang · 4 shared papers, 2025–2026 · strength 1.26
   • Paper Association between female reproductive factors and new-onset pancreatic cancer risk: a prospective cohort study. DOI 10.1097/cej.0000000000000987↗
   • Paper Elevated circulating glycine levels are associated with reduced pancreatic cancer risk: A prospective cohort study base… DOI 10.1016/j.pan.2025.12.015↗
   • Paper Metabolic signatures of lipid dysregulation and inflammation characterize pancreatic cancer risk in type 2 diabetes mel… DOI 10.1016/j.diabres.2026.113230↗
3. Yongxing Du · 4 shared papers, 2025–2026 · strength 1.26
   • Paper Association between female reproductive factors and new-onset pancreatic cancer risk: a prospective cohort study. DOI 10.1097/cej.0000000000000987↗
   • Paper Elevated circulating glycine levels are associated with reduced pancreatic cancer risk: A prospective cohort study base… DOI 10.1016/j.pan.2025.12.015↗
   • Paper Metabolic signatures of lipid dysregulation and inflammation characterize pancreatic cancer risk in type 2 diabetes mel… DOI 10.1016/j.diabres.2026.113230↗
4. Chengfeng Wang · 2 shared papers, 2025–2026 · strength 0.59
   • Paper Elevated circulating glycine levels are associated with reduced pancreatic cancer risk: A prospective cohort study base… DOI 10.1016/j.pan.2025.12.015↗
   • Paper Prevalence, clinicopathological features, and prognosis of diabetes in pancreatic cancer: A single-center retrospective… DOI 10.1016/j.pan.2025.11.004↗
5. Shurui Zhou · 3 shared papers, 2022–2024 · strength 0.56
   • Paper Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer. DOI 10.1016/j.mcp.2023.101948↗
   • Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
   • Paper A LETM2-Regulated PI3K-Akt Signaling Axis Reveals a Prognostic and Therapeutic Target in Pancreatic Cancer. DOI 10.3390/cancers14194722↗
6. Ziyi Zhong · 3 shared papers, 2022–2024 · strength 0.54
   • Paper Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in… DOI 10.1038/s41416-024-02880-8↗
   • Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
   • Paper A LETM2-Regulated PI3K-Akt Signaling Axis Reveals a Prognostic and Therapeutic Target in Pancreatic Cancer. DOI 10.3390/cancers14194722↗
7. Kaihong Huang · 3 shared papers, 2022–2024 · strength 0.54
   • Paper Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in… DOI 10.1038/s41416-024-02880-8↗
   • Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
   • Paper A LETM2-Regulated PI3K-Akt Signaling Axis Reveals a Prognostic and Therapeutic Target in Pancreatic Cancer. DOI 10.3390/cancers14194722↗
8. Yuzhou Huang · 2 shared papers, 2024 · strength 0.42
   • Paper Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer. DOI 10.1016/j.mcp.2023.101948↗
   • Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
9. Jiajia Li · 2 shared papers, 2024 · strength 0.40
   • Paper Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in… DOI 10.1038/s41416-024-02880-8↗
   • Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
10. Jinmao Zou · 2 shared papers, 2024 · strength 0.40
    • Paper Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in… DOI 10.1038/s41416-024-02880-8↗
    • Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
11. Yue Zhao · 2 shared papers, 2024 · strength 0.40
    • Paper Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in… DOI 10.1038/s41416-024-02880-8↗
    • Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
12. Guoda Lian · 2 shared papers, 2022–2024 · strength 0.34
    • Paper Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in… DOI 10.1038/s41416-024-02880-8↗
    • Paper A LETM2-Regulated PI3K-Akt Signaling Axis Reveals a Prognostic and Therapeutic Target in Pancreatic Cancer. DOI 10.3390/cancers14194722↗
13. Shaojie Chen · 2 shared papers, 2022–2024 · strength 0.34
    • Paper Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in… DOI 10.1038/s41416-024-02880-8↗
    • Paper A LETM2-Regulated PI3K-Akt Signaling Axis Reveals a Prognostic and Therapeutic Target in Pancreatic Cancer. DOI 10.3390/cancers14194722↗
14. Yaqing Li · 2 shared papers, 2022–2024 · strength 0.34
    • Paper Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in… DOI 10.1038/s41416-024-02880-8↗
    • Paper A LETM2-Regulated PI3K-Akt Signaling Axis Reveals a Prognostic and Therapeutic Target in Pancreatic Cancer. DOI 10.3390/cancers14194722↗
15. Kege Yang · 2 shared papers, 2022–2024 · strength 0.34
    • Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
    • Paper A LETM2-Regulated PI3K-Akt Signaling Axis Reveals a Prognostic and Therapeutic Target in Pancreatic Cancer. DOI 10.3390/cancers14194722↗
16. Shanglong Liu · 1 shared paper, 2026 · strength 0.32
    • Paper Metabolic signatures of lipid dysregulation and inflammation characterize pancreatic cancer risk in type 2 diabetes mel… DOI 10.1016/j.diabres.2026.113230↗
17. Shuisheng Zhang · 1 shared paper, 2025 · strength 0.26
    • Paper Prevalence, clinicopathological features, and prognosis of diabetes in pancreatic cancer: A single-center retrospective… DOI 10.1016/j.pan.2025.11.004↗
18. Shunda Wang · 1 shared paper, 2025 · strength 0.26
    • Paper Prevalence, clinicopathological features, and prognosis of diabetes in pancreatic cancer: A single-center retrospective… DOI 10.1016/j.pan.2025.11.004↗
19. Hui Deng · 1 shared paper, 2024 · strength 0.23
    • Paper Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer. DOI 10.1016/j.mcp.2023.101948↗
20. Jianchang Shu · 1 shared paper, 2024 · strength 0.23
    • Paper Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer. DOI 10.1016/j.mcp.2023.101948↗
21. Yuzhou Huang · 1 shared paper, 2024 · strength 0.20
    • Paper Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in… DOI 10.1038/s41416-024-02880-8↗
22. Hanming Yao · 1 shared paper, 2024 · strength 0.20
    • Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
23. Shaojie Chen · 1 shared paper, 2024 · strength 0.20
    • Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
24. W.-P. Li · 1 shared paper, 2015 · strength 0.04
    • Paper Differential expression profiling of microRNAs in para-carcinoma, carcinoma and relapse human pancreatic cancer. DOI 10.1007/s12094-014-1249-8↗
25. Da Fu · 1 shared paper, 2015 · strength 0.04
    • Paper Differential expression profiling of microRNAs in para-carcinoma, carcinoma and relapse human pancreatic cancer. DOI 10.1007/s12094-014-1249-8↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.